Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Fingolimod

A sphingosine-1-phosphate receptor modulator that keeps lymphocytes inside the lymph nodes. First synthesised in Japan in 1992, in 2010 it became the first oral medicine approved in the United States to modify the course of relapsing multiple sclerosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It derives from myriocin, a substance made by the fungus Isaria sinclairii, used in traditional Chinese medicine as an eternal-youth remedy.

FingolimodGo to the active ingredient →
FingolimodActive ingredientFingolimodCat. No. P-F049-001CAS 162359-55-9
Fingolimod-d4Isotopically labelledFingolimod-d4Cat. No. P-F049-023CAS 1346747-38-3

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.